Neoadjuvant Nab-Paclitaxel and S-1 in Resectable Pancreatic Cancer
NCT04808687
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
72
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Neoplasms
Interventions
DRUG:
Nab paclitaxel and S-1
Sponsor
Tianjin Medical University Cancer Institute and Hospital